Skip to main content
OpenTrials
Completed

NCT Number: NCT04925882

Erector Spinae Plane Block in Lumbar Release Surgery

The aim of this study is to observe or not a reduction in the consumption of morphine within 72 hours of the realization of an erector spinae plane block when preparing for a non-instrumented spine surgery.

Completed

Looking for future studies?

Notify Me

Key information

Age range

18 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Clinique Saint Jean

Saint-Jean-de-Védas, 34430, France

About this study

Posterior lumbar spine surgery is surgery described by patients as painful. While fusion surgery seems more painful than simple release surgery, release surgery remains a painful surgery for patients. The management of post-operative pain is therefore a priority for anesthesiological-surgical teams.

Multimodal analgesia, already recognized for other surgeries, is one of the keys to success, combining oral analgesics and regional local anesthetics.

The recourse to the realization of a block of the erector muscles of the spine was described for the first time in 2016, it is described there in the literature as not presenting any particular risk, simple to apply and having a satisfactory analgesia action. However, this process is little described in the context of spine surgery and even less in the context of randomized controlled trials.

The investigator therefore hypothesize that the realization of a block of the erector muscles of the spine, because of its satisfactory analgesia action mentioned above, will decrease the consumption of postoperative morphine and at the same time reduce the side effects due to the latter.

On the other hand, no study has evaluated the effectiveness of spinal block as part of an Enhanced Rehabilitation After Surgery (RAAC) program. Indeed, the effectiveness of this practice has already been proven in a context of conventional care, but to date no studies have been carried out in the context of care involving the original elements of the RAAC, such as rapid mobilization and multimodal oral analgesia, which could impact the effectiveness of the erector muscle blocks of the spine.

At the Clinique Saint Jean Sud de France, the management of spine surgeries is part of this Improved Rehabilitation After Surgery (RAAC) process, which is why it seemed relevant to the investigator to carry out a randomized, controlled study. , double-blind to assess the consumption of postoperative morphine during the 72 hours following a lumbar arthrodesis in this context of care.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Patient with medical insurance.
  • Patient twho received information about study and signes a consent to participate in the study.
  • Major patient to be operated on for lumbar release surgery without arthrodesis or osteosynthesis posterior (herniated disc repair, one or two level recalibration, laminectomy) +/- implant interlaminar.
  • Patient with an ASA score of 1, 2 or 3.

Exclusion criteria

  • Minor patient.
  • Patient with morphine intolerance
  • Patient with allergy to local anesthetics.
  • Patient consuming morphine for more than 3 months.
  • Pregnant or breastfeeding patient.
  • Patient scheduled for cancer surgery or trauma surgery.
  • Patient participating in another interventional study.
  • Patient with a history of lumbar arthrodesis.
  • Patient requiring lumbar surgery with arthrodesis.
  • Patient refusing to sign the consent form.
  • Patient for whom it is impossible to give informed information.
  • Patient under the protection of justice, under curatorship or under tutorship.

Treatment and study plan

Erector Spinae Plane Block

Procedure

After installing the sleeping patient and identifying the surgical level by the surgeon, the anesthetist will perform the erector spinae plane block. The anesthetist performs an ultrasound to view the spine and erector muscles and identifies the transverse processes of the vertebra involved in the surgery. Once the location has been made, the anesthetist injects the anesthetic product under ultrasound control between the erector muscle of the spine and its anterior fascia, the trajectory of the needle being thus visualized throughout the procedure. The anesthetist bilaterally injects 3ml/kg of solution with a maximum of 30ml injected.

Drug : Levobupivacaïne 2,5mg/ml.

Primary outcomes

  1. Consumption of postoperative morphine within 72 hours of the operation

    Time frame: 72 hours

Secondary outcomes

  1. Digital visual scale to assess pain of patient within 72 hours of the operation.

    Time frame: 72 hours

    Numeric scale numbered from 0 to 10. 0 : no pain, 10 : worst pain possible.

  2. Onset of nausea and vomiting within 72 hours of the operation.

    Time frame: 72 hours

    Onset of nausea/vomiting or taking an anti-vomiting treatment within 72 hours of the operation.

  3. Onset of complication within 30 days of the operation.

    Time frame: 30 days

  4. Walking perimeter measurement by the physiotherapist during the 72 hours following the intervention.

    Time frame: 72 hours

    Measurement of the maximum distance traveled without stopping in meter with or without assistance.

Sponsors and collaborators

Lead sponsor

Clinique Saint Jean, France

Other

Registry information

Official study title

Erector Spinae Plane Block in Lumbar Release Surgery : Double-blind, Randomized Controlled Trial

Acronym: MERLIBERTION

Important dates

Study start
2022
Primary completion
2022
Study completion
2022
First posted
Jun 14, 2021
Registry last updated
Nov 26, 2025

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.